K. Bartelheim

SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis

Martin Hasselblatt, Inga Nagel, Florian Oyen et al. · Acta Neuropathologica · 2014 · 196 citations · Full text

Life Sciences, Genetics, Oncology +16

High‐resolution genomic analysis suggests the absence of recurrent genomic alterations other than <i>SMARCB1</i> aberrations in atypical teratoid/rhabdoid tumors

Martin Hasselblatt, Sarah Isken, Anna Linge et al. · Genes Chromosomes and Cancer · 2012 · 154 citations

Medicine, Genetics, Oncology +17

Improved 6‐year overall survival in <scp>AT</scp>/<scp>RT</scp> – results of the registry study Rhabdoid 2007

K. Bartelheim, Karolina Nemes, Angela Seeringer et al. · Cancer Medicine · 2016 · 92 citations · Full text

Medicine, Genetics, Oncology +13

High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB)

Martin Benesch, K. Bartelheim, Gudrun Fleischhack et al. · Bone Marrow Transplantation · 2014 · 70 citations

Medicine, Oncology, Radiation Oncology +15

ATYPICAL TERATOID RHABDOID TUMOUR

Anne‐Isabelle Bertozzi, Caroline Munzer, Fanny Fouyssac et al. · Neuro-Oncology · 2014 · 52 citations · Full text

Medicine, Oncology, Pharmacotherapy +17